A tailored course, built for your situation
Production-Grade AI in Pharmaceutical R&D Operations for Audit Teams
Implementing auditable, compliant AI systems for modern drug development oversight
The situation this course is for
As pharmaceutical companies accelerate AI adoption in drug discovery and clinical development, audit functions struggle to keep pace. Traditional audit methods fall short when assessing dynamic, data-intensive AI systems. Without structured, up-to-date guidance, audit teams risk inefficiencies, compliance gaps, and reduced influence in strategic decisions.
Who this is for
Compliance officers, audit leads, quality assurance managers, and technology risk professionals in pharmaceutical or biotech organizations overseeing AI use in R&D.
Who this is not for
This course is not for data scientists building AI models or executives seeking high-level AI overviews.
What you walk away with
- Understand how AI systems are deployed and maintained in regulated pharmaceutical R&D environments
- Apply audit frameworks tailored to machine learning pipelines, data provenance, and model lifecycle management
- Evaluate system documentation for completeness, traceability, and compliance readiness
- Use standardized templates to assess validation, monitoring, and change control processes
- Lead cross-functional discussions with data science and R&D teams using shared terminology and expectations
The 12 modules (with all 144 chapters)
- Defining AI and machine learning in life sciences
- Current use cases in drug discovery and clinical trials
- Regulatory landscape shaping AI deployment
- The audit function’s expanding scope
- Key stakeholders in AI governance
- Lifecycle overview of AI systems in R&D
- Differentiating research-grade vs production-grade AI
- Common misconceptions about AI in regulated environments
- Trends driving audit involvement in AI
- Terminology alignment across technical and compliance teams
- Case study: AI in preclinical target identification
- Module 1 summary and action checklist
- FDA guidance on AI/ML in medical products
- EMA perspectives on adaptive algorithms
- ICH Q9 and risk-based approaches to AI
- GxP implications for AI-driven processes
- Data integrity principles (ALCOA+)
- ISO standards applicable to AI validation
- Emerging frameworks from health authorities
- Aligning AI practices with 21 CFR Part 11
- Audit trail requirements for model changes
- Documentation expectations for algorithmic decisions
- Preparing for regulatory inspections of AI systems
- Module 2 summary and compliance mapping tool
- Core elements of production AI infrastructure
- Model training, validation, and test environments
- Data ingestion and preprocessing pipelines
- Feature engineering and storage
- Model serving and API integration
- Monitoring and logging frameworks
- Version control for models and data
- Containerization and reproducibility
- Access controls and authentication layers
- System scalability and reliability
- Disaster recovery and backup protocols
- Module 3 summary and architecture review checklist
- Principles of data lineage in AI workflows
- Tracking raw data sources and transformations
- Metadata standards for datasets
- Data quality assessment frameworks
- Handling missing or biased data
- Consent and privacy considerations
- Data access and retention policies
- Audit-ready data documentation
- Validating data preprocessing steps
- Reproducibility of data pipelines
- Tools for automated data tracing
- Module 4 summary and data audit template
- Model development lifecycle phases
- Hypothesis formulation and objective setting
- Algorithm selection and justification
- Training data representativeness
- Cross-validation and performance metrics
- Bias and fairness assessments
- External validation strategies
- Documentation of modeling decisions
- Versioning of trained models
- Model card and fact sheet standards
- Peer review processes in model development
- Module 5 summary and validation assessment rubric
- Types of changes in AI systems
- Impact assessment for model updates
- Change control board roles and processes
- Versioning data, code, and models
- Rollback and fallback procedures
- Testing requirements for new versions
- Documentation of change justifications
- Audit trails for system modifications
- Monitoring post-deployment performance shifts
- Managing technical debt in AI pipelines
- Automated change detection tools
- Module 6 summary and change log template
- Key performance indicators for AI models
- Statistical process control for predictions
- Concept drift and data drift detection
- Monitoring input data distributions
- Alerting thresholds and escalation paths
- Human-in-the-loop review processes
- Feedback loops from clinical or operational outcomes
- Logging model predictions and decisions
- Performance dashboards for audit review
- Scheduled model re-evaluation cycles
- Handling model underperformance
- Module 7 summary and monitoring checklist
- Regulatory need for model explainability
- Global standards on algorithmic transparency
- Techniques for model interpretation
- Local vs global explanations
- SHAP, LIME, and other explanation methods
- Documentation of interpretability results
- Communicating uncertainty to stakeholders
- Explainability in safety-critical decisions
- Limitations of current interpretability tools
- Audit trails for explanation generation
- Case study: explaining a clinical trial enrollment model
- Module 8 summary and interpretability review guide
- Risk categorization for AI applications
- Hazard analysis and risk mitigation
- Failure mode and effects analysis (FMEA)
- Patient safety implications
- Regulatory and reputational risks
- Risk-based audit planning
- Third-party vendor risk assessment
- Business continuity considerations
- Incident response for AI failures
- Risk communication strategies
- Periodic risk reassessment
- Module 9 summary and risk matrix template
- Common vendor engagement models
- Contractual requirements for AI deliverables
- Right-to-audit clauses
- Assessing vendor quality management systems
- Reviewing third-party validation reports
- Data sharing and IP protection
- Oversight of cloud-based AI platforms
- Vendor performance monitoring
- Audit of outsourced model development
- Managing multi-vendor ecosystems
- Transition and exit planning
- Module 10 summary and vendor audit checklist
- Defining audit scope and objectives
- Assembling cross-functional audit teams
- Pre-audit documentation requests
- Interview techniques for technical staff
- Sampling strategies for AI workflows
- On-site vs remote audit approaches
- Evaluating evidence sufficiency
- Drafting audit findings and observations
- Reporting to management and regulators
- Follow-up on corrective actions
- Continuous audit models
- Module 11 summary and audit plan template
- Emerging technologies in AI and drug development
- Regulatory sandbox initiatives
- AI in real-world evidence and post-market surveillance
- Generative AI applications in R&D
- Ethical frameworks for AI innovation
- Building internal AI governance committees
- Audit’s role in enterprise AI strategy
- Professional development for audit teams
- Sharing best practices across organizations
- Anticipating next-generation compliance challenges
- Advancing the audit profession in the AI era
- Module 12 summary and future-readiness roadmap
How this maps to your situation
- Preparing for an upcoming audit of an AI-driven clinical trial platform
- Supporting a company-wide initiative to standardize AI governance
- Responding to increased regulatory scrutiny on algorithmic decision-making
- Enhancing internal capabilities to review third-party AI solutions
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 45, 60 hours of total engagement, designed for flexible, self-paced learning.
How this compares to the alternatives
Unlike generic AI ethics courses or technical data science programs, this course is specifically tailored to audit and compliance professionals in pharmaceutical R&D, offering actionable frameworks rather than theoretical overviews.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.